USE OF EXTERNAL counting of the clearance of a radioactive inert gas such as 133 xenon to measure blood flow is widespread. 13 However, the technique involves certain assumptions which may not be correct when comparing a control to an experimental measurement. 4 ' 6 In the study of cerebral blood flow the use of the 133 xenon technique has recently been criticized. 6 The main arguments used were that the extracerebral tissues were not excluded from the counting field, the capillary permeability for xenon may alter and the analysis of the clearance curve is often not as straightforward as a simple biexponential curve. The radio-labelled microsphere technique was proposed as a viable alternative. 6 However, this microsphere technique has certain drawbacks. The number of flow determinations is limited by the number of differently labelled microspheres available. 6 The alterations in flow may not be monitored as an experiment proceeds, and the addition of an isotope, such as 95 Nb, with a large amount of backscatter into low keV ranges, will render inaccurate counting of low keV isotopes ( 141 Ce). In addition, it is possible that serial lodging of spheres in the tissue may alter flow.
The present study has resolved some of these disadvantages by external counting of standard injections of microspheres with a single radiolabel. 
Methods and Materials
Cerebral blood flow (CBF) was studied in 4 baboons (Papio ursinus) by a modified microsphere technique. The CBF at normocapnia was measured and then the alteration of flow was determined with hypercapnia and hypocapnia, and after returning to a normocapnic situation. The baboons were sedated with an intramuscular injection of 0.2 ml phencyclidene (Sernylan, Bio-ceutic) and surgical anesthesia induced by intravenous injection of 50 mg thiopentone (Intraval Sodium M + B). The animals were intubated and ventilated using a Harvard positive pressure ventilator.
A catheter was placed retrograde in the left femoral artery for recording arterial blood pressure using a Statham P23AA transducer and for removal of arterial blood for estimation of Paco 2 , Pao 2 , pH, hemoglobin (Hb) and oxygen saturation percentage (HbO 2 ) prior to each flow determination. A similar catheter was placed in the right brachial artery. Blood was collected from this catheter directly into preweighed Packard scintillation vials for counting of blood microsphere content (C B ) at each injection point. A third catheter was passed via the right femoral artery into the left atrium. This was used for injection of the microspheres. Lastly, a catheter was placed retrograde in the internal jugular vein with its tip in the sigmoid sinus. This was used to collect mixed cerebral venous blood for determination of cerebral venous Hb and HbO 2 . The position of the tip of each catheter was confirmed radiologically.
In addition, the skin and temporalis muscle over the parietal area of the brain were removed and a 50 mm diameter sodium iodide crystal scintillation detector was placed over the region. The detector was fitted with a lead collimator to cone the counting field into one of 20 mm in diameter and was further collimated 50 mm into a lead collimation tube to exclude all noncerebral tissue from the counting field. Four leads from a Beckman EEG recorder were screwed into the skull in this region and the area of skull under the detector was carefully marked. The detector was connected to a Nuclear Enterprises Amplifier and Ratemeter system and the analog scintillation signal was displayed, together with pulsatile and mean arterial blood pressure and respiratory % CO 2 (from a capnograph) on a chart recorder. Also, the analog signal was converted into a digital form using appropriate electronics (Nuclear Enterprises).
After surgery the thiopentone was continuously infused (i.v.) at a rate sufficient to maintain anesthesia at a light level (0.5-2.5 mg/min). This level of anesthesia was achieved by maintaining the rhythms of the electroencephalograph at a dominant alpha frequency.
The microspheres used in this study were 15 jim in diameter and were labelled with 46 Sc. They were supplied as a suspension in saline with Tween 80 as a surfactant (3M). The following protocol was used for each flow determination. Arterial and cerebral venous blood samples were taken. These were used for determination of arterial Pco 2 , Po 2 , pH, hemoglobin (Hb), hemoglobin-oxygen saturation (HbO 2 ) and venous Hb and HbO 2 . The EEG was monitored and confirmed to be within the alpha frequency range. Rectal temperature was maintained at 37.5 ± 1.5°C (mean ± range). The microspheres were vigorously shaken using a flask shaker for at least 5 minutes. Meanwhile, the background activity of the brain was recorded for at least 2 minutes. A 100 n\ quantum of the mixed microspheres was drawn into a syringe. Meanwhile, blood was allowed to flow directly from the brachial artery catheter into a preweighed scintillation vial. The bolus of spheres was injected rapidly into the left atrial catheter and was flushed into the heart using 5 ml of saline. Blood sample collection continued for exactly one minute and at the end the mass of blood collected (M) was determined by reweighing the vial. The volume of this blood and, therefore, the blood sampling rate in ml/min was determined by dividing M by the mass of a calibrated sample of 5 ml of blood and multiplying by 5. During the injection of spheres the radioactivity of the brain was continuously recorded. The arrival of the spheres and their entry into the cerebral circulation was accompanied by a step increase in recorded radio activity. The amplitude of this step was used to measure blood flow.
After the baseline determination at a Paco 2 of 35 ± 2.5 and Pao 2 of 80 ± 10 mm Hg (mean ± range, normal blood gases at an altitude of 1600 meters), the procedure was repeated with hypercapnia (55 ± 2.5 mm Hg), hypocapnia (25 ± 2.5 mm Hg) and finally at normocapnia again. At the end of the experiment the animal was killed with an overdose of barbiturate anesthetic and the head dissected to remove, 1) the area of bone underneath the detector, 2) the dura under the detector and 3) the cerebrum under the detector to a depth of 15 mm below the surface of the cortex. These samples were placed in preweighed scintillation vials and were counted together with the reference blood samples from the 4 flow determinations in a well type gamma spectrometer (Packard). The window settings used throughout for the counting of 46 Sc was 1000-1500 keV.
Computation of Blood Flow
The external counting of the arrival in the brain of the 4 aliquots of spheres labelled with 46 Sc gave a series of step changes in recorded count. The size of each step was measured by calculating the mean background before and after injection of spheres and calculating the difference between these means. The amplitude of each step is proportional to the number of spheres arriving at the time of injection and is therefore an index of blood flow at that time. The relative size of each step was calculated by adding all 4 steps together and calculating the % that each individual step was of the total (table 1) .
The postmortem counting of reference blood samples and the brain tissue was then used to determine cerebral blood flow. The total activity counted with the external scintillation detector was the direct result of microspheres remaining in the brain blood vessels under the detector. Therefore, when this section of tissue was counted in the well spectrometer the % distribution of the external counting was used to separate the spectrometer total into the 4 component parts representing blood flow with the 4 injections of microspheres. The blood reference samples were also counted in the spectrometer and thus each flow could be calculated using the formula 6 : C T * R* 100 Flow (ml/min/100 g) = c . T C T = Component one of spectrometer tissue count C B = Blood count at time of component one external counting R = Sampling rate of blood T = Brain tissue mass (g) This process was repeated for components 2, 3 and 4.
Bone and Dura
The calculation of cerebral blood flow assumes that all of the externally counted amount was lodged in the sample of brain removed for the well spectrometer. The inaccuracy of this assumption was assessed by calculating the percentage that the bone plus dura radioactivity contaminated the brain sample. Thus the role of the tissues between the detector and brain could be estimated. The deep brain tissues would also be counted in the external field. However their involvement was expected to be small as counting efficiency decreases rapidly with the distance away from the crystal detector.
Comparison with Xenon
Lastly, the flow estimations and the responsiveness to alteration in arterial Pco 2 was compared between this new technique and with previous work in our laboratory using established 133 xenon clearance techniques. 7 Flow/unit Metabolism It has become increasingly evident that flow measurements in an organ such as the brain should be accompanied by some estimation of metabolism. 
Statistics
The measured blood flow and other variables in the normocapnic and experimental situations were routinely compared using the Student's paired f-test. In addition, an F test of the variances was performed. When the variances were found to be significantly different a Wilcoxon rank sum test was used in substitution for the Mest.
Results
In the present experiments arterial Pco 2 was altered from a mean baseline value of 34.2 ± 1 . 1 mm Hg to 55.1 ± 0.8 mm Hg, then to 25.7 ± 0.4 and finally to 34.4 ± 0.8 mm Hg. The mean cerebral blood flow measured at these different Pco 2 values together with the concurrent measurements of Pao 2 , mean arterial blood pressure (MBP) and the CBF per unit CMRO 2 are shown in table 2. Hypercapnia was associated with an increased CBF from the baseline value of 53.1 ± 7.3 ml/min per 100 g of tissue to 85.4 ± 13.4 ml/min/100 g (p < 0.05). This flow alteration was not accompanied by a significant alteration in Pao 2 or MBP. However, the ratio of CBF to CMRO 2 was significantly increased (p < 0.025) indicating that the primary action of the increase in arterial CO 2 was to increase CBF by a direct vasodilator action on cerebral blood vessels.
Hypocapnia by hyperventilation was associated with a decrease in CBF to 31.7 ± 4.2 ml/min/100 g (p < 0.025). This change was due to a direct vasoconstrictor action on cerebral blood vessels as the CBF per unit CMRO 2 was decreased below baseline (p < 0.05). In addition there was a significant increase in Pao 2 (p < 0.01) and a decrease in MBP (p < 0.05). These changes in Pao 2 and MBP are, however, insufficient to alter CBF by themselves 9 and are possibly side effects of the hyperventilation process.
The second normocapnic measurement showed that the variables that were measured all returned to values which were not significantly different from those found in the initial normocapnic baseline.
Comparison with Xenon Table 3 shows previously recorded values of mean CBF measured by 133 xenon 7 and the responsiveness of this index to the same alteration in Paco 2 as the present study. In addition, the percentage changes from normocapnic baseline were calculated. These Thus, the present technique may more closely approximate to measurement of cortical gray matter rather than cortical and subcortical white matter.
The major first assumption is that the gamma count from the postmortem tissue can be correlated to the data generated by the external scintillation detector. The bone and dura under the external detector could only have contributed a small percentage error to the technique. Tissues far away from the detector would also be expected to contribute little to the external count as the signal generated by these deep tissues is proportional to the reciprocal of the square of the distance from the detector. Thus, it is likely that the external count was mainly generated from the first layer of cortex under the detector. The observation that the blood flow value from the present experiment more closely approximates that found in the fast clearing component (gray matter) of the xenon curve further supports this probability. The approximation may, in fact, be even better than reported here if pure gray matter had been sampled instead of the mixed graywhite wedge of tissue. This, however, still remains uncertain.
The responsiveness of the microsphere flow to alteration in CO 2 is also similar to the xenon gray matter changes. The microsphere data showed a change in flow of 3.53% per mm Hg CO 2 . This is similar to the CO 2 reactivity generally quoted, 9 but lower than that reported for the microsphere technique in the dog. 10 Comparisons with other identical experiments in our laboratory using 133 xenon show the Bone and Dura The mean ratio of spectrometer sphere count in bone and dura to the count in the underlying cerebral tissue was found to be only 7.7% of the cerebral count and, therefore, artifacts due to contamination by counts derived from bone or dura blood flow would not significantly alter the measured cerebral flow response to stimulii.
Discussion
This study was stimulated by a need for a method of CBF measurement which would avoid the assumptions of inert gas clearance technique, but preserve its repetitive ease of measurement. The present technique may provide the answer to such a need. In removing some assumptions, however, new ones have taken their place. present CO 2 reactivity to be greater than before. 7 However, in comparison to our previous baboon study using 133 xenon and a different anesthetic the present values are low. 11 Therefore, it seems that reported CO 2 reactivity depends on the flow measurement technique, the species studied, and the type of anesthesia used.
Secondly, it may have been expected that sequential blocking of cerebrovascular capillaries would have reduced normocapnic blood flow. The present data show a small decrease between the first normocapnic determination and the final measurement. However, the difference was not significant and thus at least 4 sequential measurements of flow may be made using this technique. In effect, it is probable that many more measurements are possible as the number of spheres per injection is minute in comparison to the billions of capillaries in the systemic cardiovascular system.
The present technique obviates many of the criticisms of the 133 xenon clearance method. Extracerebral tissues were excluded from the counting field by removal of skin and muscle with heavy shielding and collimation of the detector. Changes in capillary permeability would not have produced artifacts in the number of spheres lodged in the tissue as the spheres were sufficiently large to lodge in precapillary resistance vessels. In addition, there is no complex clearance curve to analyse, and only simple mathematical calculations to make.
It remains to be seen if this modification of the microsphere technique will prove useful. However, it does seem to combine the best features of inert gas clearance techniques and multilabel microsphere injection.
